rs189108830

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006017.3(PROM1):​c.55T>G​(p.Ser19Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0103 in 1,613,608 control chromosomes in the GnomAD database, including 195 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0092 ( 24 hom., cov: 32)
Exomes 𝑓: 0.010 ( 171 hom. )

Consequence

PROM1
NM_006017.3 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.21

Publications

11 publications found
Variant links:
Genes affected
PROM1 (HGNC:9454): (prominin 1) This gene encodes a pentaspan transmembrane glycoprotein. The protein localizes to membrane protrusions and is often expressed on adult stem cells, where it is thought to function in maintaining stem cell properties by suppressing differentiation. Mutations in this gene have been shown to result in retinitis pigmentosa and Stargardt disease. Expression of this gene is also associated with several types of cancer. This gene is expressed from at least five alternative promoters that are expressed in a tissue-dependent manner. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
PROM1 Gene-Disease associations (from GenCC):
  • retinal macular dystrophy type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • inherited retinal dystrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa 41
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • cone-rod dystrophy 12
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • cone-rod dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinitis pigmentosa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Stargardt disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0028541088).
BP6
Variant 4-16075852-A-C is Benign according to our data. Variant chr4-16075852-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 193330.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0571 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PROM1NM_006017.3 linkc.55T>G p.Ser19Ala missense_variant Exon 2 of 28 ENST00000447510.7 NP_006008.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PROM1ENST00000447510.7 linkc.55T>G p.Ser19Ala missense_variant Exon 2 of 28 1 NM_006017.3 ENSP00000415481.2

Frequencies

GnomAD3 genomes
AF:
0.00922
AC:
1403
AN:
152130
Hom.:
24
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00234
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0306
Gnomad ASJ
AF:
0.00807
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00456
Gnomad FIN
AF:
0.00772
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0101
Gnomad OTH
AF:
0.0100
GnomAD2 exomes
AF:
0.0149
AC:
3699
AN:
248340
AF XY:
0.0130
show subpopulations
Gnomad AFR exome
AF:
0.00182
Gnomad AMR exome
AF:
0.0638
Gnomad ASJ exome
AF:
0.00747
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00943
Gnomad NFE exome
AF:
0.00901
Gnomad OTH exome
AF:
0.0118
GnomAD4 exome
AF:
0.0104
AC:
15236
AN:
1461360
Hom.:
171
Cov.:
31
AF XY:
0.0100
AC XY:
7300
AN XY:
726918
show subpopulations
African (AFR)
AF:
0.00167
AC:
56
AN:
33480
American (AMR)
AF:
0.0589
AC:
2630
AN:
44630
Ashkenazi Jewish (ASJ)
AF:
0.00750
AC:
196
AN:
26124
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39694
South Asian (SAS)
AF:
0.00404
AC:
348
AN:
86136
European-Finnish (FIN)
AF:
0.00877
AC:
468
AN:
53388
Middle Eastern (MID)
AF:
0.00399
AC:
23
AN:
5768
European-Non Finnish (NFE)
AF:
0.00992
AC:
11029
AN:
1111778
Other (OTH)
AF:
0.00803
AC:
485
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
886
1772
2659
3545
4431
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
446
892
1338
1784
2230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00921
AC:
1402
AN:
152248
Hom.:
24
Cov.:
32
AF XY:
0.00889
AC XY:
662
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.00234
AC:
97
AN:
41534
American (AMR)
AF:
0.0304
AC:
465
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00807
AC:
28
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00477
AC:
23
AN:
4824
European-Finnish (FIN)
AF:
0.00772
AC:
82
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0101
AC:
686
AN:
68022
Other (OTH)
AF:
0.00994
AC:
21
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
64
129
193
258
322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00892
Hom.:
19
Bravo
AF:
0.0115
TwinsUK
AF:
0.00998
AC:
37
ALSPAC
AF:
0.0114
AC:
44
ESP6500AA
AF:
0.00225
AC:
9
ESP6500EA
AF:
0.00899
AC:
75
ExAC
AF:
0.0126
AC:
1528
EpiCase
AF:
0.00823
EpiControl
AF:
0.0102

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Nov 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 22, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:2
May 22, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Stargardt disease 4 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Retinal macular dystrophy type 2 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Cone-rod dystrophy 12 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Retinitis pigmentosa Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
8.7
DANN
Benign
0.60
DEOGEN2
Benign
0.22
T;.;.;.;.;T;T;.
Eigen
Benign
-0.64
Eigen_PC
Benign
-0.65
FATHMM_MKL
Benign
0.22
N
LIST_S2
Benign
0.43
T;T;T;.;T;.;T;T
MetaRNN
Benign
0.0029
T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.63
N;N;N;N;N;N;.;.
PhyloP100
1.2
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-1.3
N;N;N;N;N;N;N;D
REVEL
Benign
0.017
Sift
Benign
0.15
T;T;T;T;T;T;T;D
Sift4G
Benign
0.15
T;T;T;T;T;T;.;.
Vest4
0.026
ClinPred
0.0037
T
GERP RS
2.0
PromoterAI
-0.021
Neutral
Varity_R
0.11
gMVP
0.39
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs189108830; hg19: chr4-16077475; API